As a proof of concept, μLC-MS/MSanalysis of Alzheimer’s disease patient-derived iPSC cerebralorganoid reveals differential lipid metabolism depending on APOE phenotype(E3/3 vs E4/4). This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.